5-methoxyindole-2-carboxylic acid | CAS:4382-54-1

We serve 5-methoxyindole-2-carboxylic acid CAS:4382-54-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-methoxyindole-2-carboxylic acid

Chemical Name:5-methoxyindole-2-carboxylic acid
CAS.NO:4382-54-1
Synonyms:5-methoxyindole-2-carboxylic acid
5-methoxy-1H-indole-2-carboxylic acid
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 447.6±25.0 °C at 760 mmHg
Melting Point 199-201 °C(lit.)
Molecular Formula C10H9NO3
Molecular Weight 191.183
Flash Point 224.5±23.2 °C
Vapour Pressure 0.0±1.1 mmHg at 25°C
Index of Refraction 1.677
 
Specification:
Appearance:Light yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 5-methoxyindole-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-methoxy-1H-indole-2-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-methoxy-1H-indole-2-carboxylic acid Use and application,5-methoxyindole-2-carboxylic acid technical grade,usp/ep/jp grade.


Related News: On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks.Uridine manufacturer Is it safe to travel? Airlines have suspended flights, and thousands of foreign citizens in the Chinese city of Wuhan have been evacuated back to their home countries. Many countries including the US have advised against travel to China.DECAMETHYLTETRASILOXANE supplier Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300.pyrrolidone hydrotribromide vendor Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300.In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.